CANCER IMAGING-英国正版365官方网站-365betapp中文-英国正版365官方网站-365bet足球信誉开户

[GetPortalCommentsPageByObjectIdResponse(id=2212011, encodeId=bcf322120117a, content=审稿速度:4.0
偏重的研究方向：妇科;影像;肿瘤
经验分享：一审6个月，给的小修，现在返修中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=111, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/8nAkhTQGffHyjD3fMFCdpGIUDaOnHCiabn4cae8n0YlBG3aoUIcbLn0EagmMv37rsed2b1RwApM5dFBatB7hKWA/132, createdBy=f3b95308321, createdName=颜大宝, createdTime=Thu Jun 27 23:19:07 CST 2024, time=2024-06-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2192597, encodeId=9c8d219259e50, content=审稿速度:1.0 | 投稿命中率:75.0
经验分享：快, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2798300950, createdName=ms8000002034594113, createdTime=Mon Mar 11 15:55:36 CST 2024, time=2024-03-11, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2192661, encodeId=95e0219266154, content=偏重的研究方向：影像;肿瘤
经验分享：特别慢，慎投！！！快4个月了还在reviewer assigned，催稿了也没用，最后撤稿了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=235c9199094, createdName=ms8000000818613096, createdTime=Mon Mar 11 23:17:22 CST 2024, time=2024-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2158146, encodeId=030d21581468b, content=审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤;影像
经验分享：傻逼期刊，从投到返修花了半年。建议别投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46488179511, createdName=ms7000001717279760, createdTime=Sun Sep 17 15:05:01 CST 2023, time=2023-09-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1231343, encodeId=3066123134344, content=请问在editor assign这一步要多久啊，已经过去一个半月了，是不是在editor手上时间越久越有可以能reject？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a082788397, createdName=特立独行的兔子, createdTime=Fri Jul 08 16:05:40 CST 2022, time=2022-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997493, encodeId=549a99e493c2, content=2020年12月投稿，一直没有审稿消息，催稿也不回，2021年7月拒稿，审稿意见一点也不专业，大家投稿小心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2f55541539, createdName=ms5000000910958525, createdTime=Thu Jul 08 10:51:23 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081938, encodeId=723a108193802, content=12月初投稿，第一天就给了格式上的问题意见，然后补充了一下，到现在半个月了还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c285205234, createdName=14749d31m91暂无昵称, createdTime=Sun Dec 19 23:58:10 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220864, encodeId=cb39122086441, content=有没有中了的小伙伴分享下时间线😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJJiamr5a2hbWibBztEHibkY3VvJIKvAzFJ0icpC3M1PicKHuav67U27XZn6sAQTGicDQdL5tGl8okAJY7w/132, createdBy=87412468601, createdName=若水_, createdTime=Thu May 19 10:07:03 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249428, encodeId=ea90124942802, content=审稿速度:12.0
经验分享：太慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b676514170, createdName=ms5000001242877304, createdTime=Fri Sep 16 23:44:24 CST 2022, time=2022-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181013, encodeId=b0e611810135a, content=这个期刊慎投！！！里面的文章特别垃圾！！！low的很，编辑都找不到几个~~~从投稿第一天很快改格式！！！然后一个月了还是editor assigned 特别慢！！！发了3个催稿信还不回！！！！我靠！！！是不是没人了这期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c285205234, createdName=14749d31m91暂无昵称, createdTime=Wed Jan 05 20:18:08 CST 2022, time=2022-01-05, status=1, ipAttribution=)]

2024-06-27

颜大宝

来自北京

审稿速度:4.0偏重的研究方向：妇科;影像;肿瘤经验分享：一审6个月，给的小修，现在返修中

111

展开2条回复

2024-03-11

ms8000002034594113

来自上海

审稿速度:1.0 | 投稿命中率:75.0经验分享：快

112

展开1条回复

2024-03-11

ms8000000818613096

偏重的研究方向：影像;肿瘤经验分享：特别慢，慎投！！！快4个月了还在reviewer assigned，催稿了也没用，最后撤稿了！

132

2023-09-17

ms7000001717279760

来自安徽省

审稿速度:6.0 | 投稿命中率:25.0偏重的研究方向：肿瘤;影像经验分享：傻逼期刊，从投到返修花了半年。建议别投。

127

展开4条回复

2022-07-08

特立独行的兔子

请问在editor assign这一步要多久啊，已经过去一个半月了，是不是在editor手上时间越久越有可以能reject？？

展开7条回复

2021-07-08

ms5000000910958525

2020年12月投稿，一直没有审稿消息，催稿也不回，2021年7月拒稿，审稿意见一点也不专业，大家投稿小心

130

展开8条回复

2021-12-19

14749d31m91暂无昵称

12月初投稿，第一天就给了格式上的问题意见，然后补充了一下，到现在半个月了还没动静

113

展开3条回复

2022-05-19

若水_

有没有中了的小伙伴分享下时间线😭

展开2条回复

2022-09-16

ms5000001242877304

审稿速度:12.0经验分享：太慢

2022-01-05

14749d31m91暂无昵称

这个期刊慎投！！！里面的文章特别垃圾！！！low的很，编辑都找不到几个~~~从投稿第一天很快改格式！！！然后一个月了还是editor assigned 特别慢！！！发了3个催稿信还不回！！！！我靠！！！是不是没人了这期刊

108

展开3条回复

CANCER IMAGING

相关推荐

轻松去除Excel中的空格，提升数据处理效率的实用技巧

如何应对做生意时的亏本情况？

牛奶解毒的原理是什么？

合作伙伴